Protease inhibitor resistance mutations in untreated Brazilian patients infected with HCV: Novel insights about targeted genotyping approaches-Reference-Cited by-同舟云学术

Protease inhibitor resistance mutations in untreated Brazilian patients infected with HCV: Novel insights about targeted genotyping approaches

Published:2014-07-11 Issue:10 Volume:86 Page:1714-1721
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

de Carvalho Isabel M.V.G.¹²,Alves Rafael²,de Souza Polyana A. Vasconcelos-Medeiros¹,da Silva Edvaldo F.³,Mazo Daniel³,Carrilho Flair J.³,Queiroz Artur T.L.⁴,Pessoa Mário G.³

Affiliation:

1. Viral Imunology, Butantan Institute; Avenida Doutor Vital Brasil; São Paulo Brazil

2. Applied Molecular Hepatology Laboratory (LHeMA), Hepatitis Sector, Gastroenterology Division; São Paulo Federal University; São Paulo Brazil

3. Department of Gastroenterology; University of São Paulo School of Medicine; São Paulo Brazil

4. Immunoparasitology Laboratory; Gonçalo Moniz Research Center (FIOCRUZ); Salvador BA Brazil

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jmv.24015/fullpdf

Reference52 articles.

1. The presence of resistance mutations to protease and polymerase inhibitors in Hepatitis C virus sequences from the Los Alamos databank;Alves;J Viral Hepatitis,2013

2. Susceptibility of treatment-naive hepatitis C virus (HCV) clinical isolates to HCV protease inhibitors;Bae;Antimicrob Agents Chemother,2010

3. Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3.4A protease inhibitors in treatment-naive subjects;Bartels;J Infect Dis,2008

4. Ultra-deep sequencing for the analysis of viral populations;Beerenwinkel;Curr Opin Virol,2011

5. HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors;Cento;PLoS ONE,2012

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. World-wide Prevalence of Substitutions in HCV Genome Associated With Resistance to Direct-Acting Antiviral Agents;Clinical Gastroenterology and Hepatology;2021-09

2. Molecular characterization of hepatitis C virus for subtype determination and resistance-associated substitutions detection among Chinese voluntary blood donors;Antiviral Research;2020-09

3. Prevalence and Factors Related to Natural Resistance-Associated Substitutions to Direct-Acting Antivirals in Patients with Genotype 1 Hepatitis C Virus Infection;Viruses;2018-12-21

4. Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus;Infection and Drug Resistance;2018-10

5. Molecular characterization of hepatitis C virus in end-stage renal disease patients under hemodialysis;Journal of Medical Virology;2017-11-16